BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 24518206)

  • 1. Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma.
    Affer M; Chesi M; Chen WG; Keats JJ; Demchenko YN; Roschke AV; Van Wier S; Fonseca R; Bergsagel PL; Kuehl WM
    Leukemia; 2014 Aug; 28(8):1725-1735. PubMed ID: 24518206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microhomology-mediated end joining drives complex rearrangements and overexpression of
    Mikulasova A; Ashby C; Tytarenko RG; Qu P; Rosenthal A; Dent JA; Ryan KR; Bauer MA; Wardell CP; Hoering A; Mavrommatis K; Trotter M; Deshpande S; Yaccoby S; Tian E; Keats J; Auclair D; Jackson GH; Davies FE; Thakurta A; Morgan GJ; Walker BA
    Haematologica; 2020 Apr; 105(4):1055-1066. PubMed ID: 31221783
    [No Abstract]   [Full Text] [Related]  

  • 3. Distinguishing primary and secondary translocations in multiple myeloma.
    Gabrea A; Leif Bergsagel P; Michael Kuehl W
    DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.
    Shou Y; Martelli ML; Gabrea A; Qi Y; Brents LA; Roschke A; Dewald G; Kirsch IR; Bergsagel PL; Kuehl WM
    Proc Natl Acad Sci U S A; 2000 Jan; 97(1):228-33. PubMed ID: 10618400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.
    Gabrea A; Martelli ML; Qi Y; Roschke A; Barlogie B; Shaughnessy JD; Sawyer JR; Kuehl WM
    Genes Chromosomes Cancer; 2008 Jul; 47(7):573-90. PubMed ID: 18381641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
    Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
    Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of MYC translocations in multiple myeloma cell lines.
    Dib A; Gabrea A; Glebov OK; Bergsagel PL; Kuehl WM
    J Natl Cancer Inst Monogr; 2008; (39):25-31. PubMed ID: 18647998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of immunoglobulin light chain gene aberrations as revealed by FISH in multiple myeloma and MGUS.
    Türkmen S; Binder A; Gerlach A; Niehage S; Theodora Melissari M; Inandiklioglu N; Dörken B; Burmeister T
    Genes Chromosomes Cancer; 2014 Aug; 53(8):650-6. PubMed ID: 24729354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole Exome Sequencing in Multiple Myeloma to Identify Somatic Single Nucleotide Variants and Key Translocations Involving Immunoglobulin Loci and MYC.
    Walker BA
    Methods Mol Biol; 2018; 1792():71-95. PubMed ID: 29797253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex IGH rearrangements in multiple myeloma: Frequent detection discrepancies among three different probe sets.
    Kim GY; Gabrea A; Demchenko YN; Bergsagel L; Roschke AV; Kuehl WM
    Genes Chromosomes Cancer; 2014 Jun; 53(6):467-74. PubMed ID: 24585545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations of IL-6R, lck and c-myc genes in transforming monoclonal gammopathies of undetermined significance.
    Gernone A; Dammacco F
    Br J Haematol; 1996 Jun; 93(3):623-31. PubMed ID: 8652383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent occurrence of large duplications at reciprocal genomic rearrangement breakpoints in multiple myeloma and other tumors.
    Demchenko Y; Roschke A; Chen WD; Asmann Y; Bergsagel PL; Kuehl WM
    Nucleic Acids Res; 2016 Sep; 44(17):8189-98. PubMed ID: 27353332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma.
    Fabris S; Storlazzi CT; Baldini L; Nobili L; Lombardi L; Maiolo AT; Rocchi M; Neri A
    Genes Chromosomes Cancer; 2003 Jul; 37(3):261-9. PubMed ID: 12759924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
    Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus.
    Våtsveen TK; Tian E; Kresse SH; Meza-Zepeda LA; Gabrea A; Glebov O; Dai HY; Sundan A; Kuehl WM; Børset M
    Leuk Res; 2009 Dec; 33(12):1670-7. PubMed ID: 19395026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of c-myc in multiple myeloma.
    Kuehl WM; Brents LA; Chesi M; Huppi K; Bergsagel PL
    Curr Top Microbiol Immunol; 1997; 224():277-82. PubMed ID: 9308252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
    Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
    Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
    Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
    Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
    Wang J; Boxer LM
    J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.
    Ryan RJ; Drier Y; Whitton H; Cotton MJ; Kaur J; Issner R; Gillespie S; Epstein CB; Nardi V; Sohani AR; Hochberg EP; Bernstein BE
    Cancer Discov; 2015 Oct; 5(10):1058-71. PubMed ID: 26229090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.